secwatch / observer
8-K filed March 5, 2024, 6:59 PM ET CIK 0001443611
regulatory confidence high sentiment negative materiality 0.70

SinglePoint Inc.: Nasdaq/NYSE listing notice — SinglePoint receives Cboe BZX minimum bid price deficiency notice; 180-day cure period until Aug 26, 2024

SinglePoint Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.92

SinglePoint Inc. received a nyse_american deficiency notice notice regarding minimum bid price.

Exchange
nyse american
Notice
deficiency notice
Deficiency
minimum bid price
Exact text from the filing
February 28, 2024, the Company received a notification letter from the Listing Qualifications Department of The Cboe BZX Exchange, Inc. (“Cboe BZX”) notifying the Company that its Common Stock did not maintain a minimum bid price of $1.00 over 30 consecutive business days as required by Cboe BZX Listing Rule 14.9(e)(1)(B) (the “Minimum Bid Price Requirement”). The receipt of the Cboe notification letter does not result in the immediate delisting of the Company’s Common Stock from the Cboe BZX and has no immediate effect on the listing or trading of the Company’s Common Stock on the Cboe BZX, u
View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0001477932-24-001038
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.